[QUOTE=Ruby]
I’m confused.
Hypothetically, without drugs/supplies, 99 out of 100 people in <insert Third World Country here> will die from some various disease. By using “leftover” drugs/supplies, only 49 out of 100 will die from disease and 2 will die from infection, contamination or some other perceived risk from the leftover supplies. In the big picture, is that a problem?
I don’t condone selling or donating used equipment like in picunurse’s example. That’s just gross on about a hundred levels. But what’s the risk of using leftover stuff that our litigation-happy society won’t let the docs use?
[/QUOTE]
Just a WAG:
1000 doses of LifeSavingDrug are given to patients in ThirdWorldCountry. The doses are “leftovers” from the QC labs and hospitals. DrugCompany gets amazing PR, everyone loves them, their stocks go up, sales go up, YAY! for everyone involved.
10 patients get ill/die from contamination/infection that is shown to be directly caused by getting LifeSavingDrug. And, OMG Media Pile-up in the fact that these are LEFTOVERS!!! Americans (Canadians, Germans, whatever) didn’t want them, they weren’t safe enough for them, but they are OK to give to ThirdWorldCountry?!?! OMG EVIL DrugCompany! Testing things, treating the poor like Guinea Pigs! Bad PR for DrugCompany. Disastrous financial effects ensue.
OK, so I’m exaggerating quite a bit, but I don’t think it’s a totally unimaginable logic for the company to take on the issue. Companies are in it for the money, for the good PR and ability to market their meds for more money, and if they can reduce their risk of bad PR that’s a good thing. The companies I have worked for DO have programs in place to send medications to regions in need of them, but only a limited amount… probably just enough to look good.
There have been times where I have thrown out unlabeled vials in the lab, knowing what they were, but short of actually testing those specific vials, there really wasn’t much way to prove it. Unless it was a narcotic, once it’s in the labs, there really isn’t much need for chain-of-custody issues, so just because there are 50 vials in a plastic bag labeled “Gentamicin Sulfate, 40mg/mL Code XXXX Lot YYYYYY” that doesn’t mean that’s what’s actually there. Not with enough certainty to send those vials back to be labeled and used, anyways (there is enough certainty to test them and say lot YYYYYY is good, since testing it pretty much proves that it is gentamicin, obviously).
In case it isn’t clear, a lot might have several thousand vials made ( for simplicity, I’ll just say 5000), and 10 or whatever brought into the lab to test (unlabeled, but placed in the bag and verified that it’s the lot of interest). Once the test confirms that the lot is good, the 4990 vials left get packaged, and maybe 2 of those get brought to a lab to do identity testing (final proof that the vial contains what the label says it does). So 4988 vials can be sent to the market. Of the 12 vials in the lab, if there are 4 left, they might be valuable to someone in desperate need of them, but they really aren’t worth much to the company compared to the rest of the lot.
I still hated throwing them out, though.